Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and ICU Medical (ICUI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Guardant Health (GH – Research Report) and ICU Medical (ICUI – Research Report) with bullish sentiments.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guardant Health (GH)
In a report released today, Daniel Brennan from TD Cowen reiterated a Buy rating on Guardant Health, with a price target of $135.00. The company’s shares closed last Thursday at $106.38.
According to TipRanks.com, Brennan is a 5-star analyst with an average return of
Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $128.13, which is a 20.2% upside from current levels. In a report issued on February 17, Robert W. Baird also initiated coverage with a Buy rating on the stock with a $120.00 price target.
See the top stocks recommended by analysts >>
ICU Medical (ICUI)
KeyBanc analyst Brett Fishbin maintained a Buy rating on ICU Medical today. The company’s shares closed last Thursday at $149.74.
According to TipRanks.com, Fishbin is a 1-star analyst with an average return of
ICU Medical has an analyst consensus of Moderate Buy, with a price target consensus of $172.00, representing a 14.0% upside. In a report issued on February 18, Piper Sandler also maintained a Buy rating on the stock with a $172.00 price target.
